Blood Coagulation & Fibrinolysis

Papers
(The median citation count of Blood Coagulation & Fibrinolysis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe75
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination24
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy20
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding18
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays17
Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans12
Comparing fondaparinux and low molecular weight heparin for thromboprophylaxis after hip and knee arthroplasty: a systematic review and meta-analysis11
Current epidemiology of deaths for disseminated intravascular coagulation11
An atypical presentation of catastrophic antiphospholipid syndrome with refractoriness to treatment11
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing10
Predictive value of miR-24-3p and miR-1277-5p in hemodialysis patients with vascular access thrombosis10
Clot waveform analysis in hemophilia carriers9
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream9
Obesity and physical exercise in hemophilia9
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays9
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome8
Time-in-therapeutic range falls as the target international normalized ratio range increases in patients on warfarin8
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency7
The procoagulant potential before and after surgery for endometriosis and its association with disease severity7
The determination of euglobulin clot lysis time reference intervals in Beckton Dickinson and Kima 3.2% sodium citrate coagulation tubes7
Disability and the social impact of hemophilia7
Genetic and clinical characterization of factor VII deficiency: insights from 34 Turkish patients7
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab7
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease6
Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis6
The physiology of hemostasis6
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report6
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant6
Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy6
Acquired Bernard–Soulier syndrome and hypodysfibrinogenaemia because of multiple myeloma5
Rare coagulation factor deficiencies: a five-year experience from a single tertiary care center in South India5
Venous thromboembolism secondary prophylaxis in elderly people (over 75 years old) with low-dose direct oral anticoagulants5
Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population5
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients5
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus5
Endotoxemia-induced protein C surge protects mice against venous thrombosis based on transient lowering of natural anticoagulants5
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism4
Haploidentical stem cell transplantation in DOCK8 deficiency: a case report of successful outcomes4
Factor VIII beyond haemophilia: a hidden regulator of venous thrombosis and endothelial dysfunction4
Is the combination of two automated rapid assays for diagnosis of heparin-induced thrombocytopenia necessary?4
Why do patients with antiphospholipid syndrome bleed? A clinical paradox4
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis4
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency4
Anticoagulant and antiplatelet activity of aqueous extracts of Citrus sinensis and Lippia alba: interactions and potential for the development of antithrombotics4
An alternative method to assess the long-term stability of frozen plasmas for coagulation testing4
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock4
Congenital factor V deficiency in Taiwan: identification of a novel variant p.Tyr1813∗ and two variants specific to East Asians3
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations3
Evaluation of a 4 min 4000g centrifugation protocol for routine coagulation assays3
Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays3
Hemolysis detection accuracy on Stago sthemO 3013
Analysis of heparin-induced thrombocytopenia diagnostic and management strategies in individuals with inconclusive antibody optical densities3
Harmonizing factor assay-related testing performed in a large laboratory network3
Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests3
The factor V H1327R (rs1800595) polymorphism is associated with venous thromboembolic events: a case–control study in southern Iran3
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment3
Association between thrombophilic gene variants and thrombosis in Iranian population: a systematic review and meta-analysis3
Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies3
A rare case of essential thrombocythemia with pseudo-hyperkalemia3
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study3
CRISPR/Cas9 mediated generation of zebrafish f9a mutant as a model for hemophilia B3
Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient3
Advances in nanotechnology for synthetic polymer hemostats: navigating precision hemostasis3
Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score2
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study2
Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII2
Warfarin versus direct oral anticoagulants in South Asian octogenarians: a retrospective review2
Disseminated intravascular coagulation in acute leukemia patients2
Management of autoimmune factor XIII deficiency in a frail, elderly patient2
Adrenal insufficiency revealing bilateral adrenal hemorrhage related to JAK2 V617F-positive essential thrombocythemia: about two cases2
Hemostatic cover in orthopedic surgery2
Safety and efficacy of thrombolytic interventions in the treatment of intermediate and high-risk pulmonary embolism2
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding2
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation2
Enhancing prediction of thrombosis associated with breast cancer using prechemotherapy hematologic and coagulation characteristics2
Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency2
Hemorrhagic complications in individuals with liver disease submitted to minor oral surgery2
A challenging case of heparin-induced skin necrosis without thrombocytopenia2
Presentation of concurrent thrombotic thrombocytopenic purpura and Graves’ disease2
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism2
Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study2
Measuring coagulopathy in pediatric craniofacial surgery2
Bleeding disorders in Saudi Arabia, causes and prevalence: a review2
Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations2
Thrombin generation assay: the present and the future2
Silent progression of hemophilic arthropathy of the elbow: case reports of three pediatric patients2
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease2
Sustained good response to rituximab in acquired von Willebrand syndrome2
Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience2
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event2
Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review2
Serum levels of inflammatory markers, sP-selectin, IL-1β, IL-6, and hsCRP are positively correlated with tissue factor transcript level of peripheral blood mononuclear cells in stroke2
Evaluation of coagulation parameters and impact of transfusion on coagulation in patients with beta thalassemia major2
Interpreting coagulation mixing study results in the era of direct oral anticoagulants2
Psychological complications among patients with congenital bleeding disorders2
The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage2
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada1
4-Factor prothrombin complex concentrates and factor VIII inhibitor bypass activity use in cardiac surgery1
Hereditary hepatic fibrinogen storage disease with a novel fibrinogen variant FGG c.1113T>A (fibrinogen Seoul III)1
Compound heterozygous mutations (p.L68R∗37 and p.T241N) lead to abnormal protein levels and structures in hereditary FVII deficiency1
Acquired factor XIII deficiency and its unprecedented association with multiple myeloma: case report and literature review1
The impact of vascular endothelial glycocalyx on the pathogenesis and treatment of disseminated intravascular coagulation1
In vitro differential inhibition of the factor XI activity assay in the setting of a lupus anticoagulant1
Noninvasive prenatal diagnosis of congenital factor XIII deficiency in Iran1
Management of gastrointestinal bleeding in a patient with type 3 von Willebrand disease and inhibitors to von Willebrand factor: a case report1
Severe acquired Factor VII deficiency complicating an aplastic anemia, successfully treated with corticosteroids1
Is dynamic change in mean platelet volume related with composite endpoint development after transcatheter aortic valve replacement?1
Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey: Erratum1
Coagulopathy following Crotaliπae snakebites in northeast Florida1
Challenges in managing severe homozygous protein c deficiency: a case report1
Nonpharmacological treatment for coping with pain1
Efficacy of extended microthrombolysis in an elderly lady with purpura fulminans1
The predictive role of platelet count for bleeding in patients with hepatitis B virus and hepatitis C virus infection1
Never too soon to be thinking about heparin-induced thrombocytopenia! A case report of early onset heparin-induced thrombocytopenia1
Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding1
Homozygous MTHFR C677T carriers develop idiopathic portal vein thrombosis 20 years earlier than wild type1
Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia1
Protein S Erlangen: a novel PROS1 gene mutation associated with quantitative protein S deficiency1
Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates1
The impact of intrauterine growth on coagulation and factor XII function in preterm infants1
Prolonged prothrombin time does not correlate with clinical bleeding symptoms in newly diagnosed paediatric leukaemia patients1
Clot waveform analysis in acute promyelocytic leukemia1
Assessment of coagulation assays on Roche Cobas t711 analyzer: performance and clinical implications1
IX international curse of continuing formation in haemophilia and other congenital coagulopathies. The role of the Laboratory in coagulation disorders. Diagnosis of von Willebrand disease1
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice1
Evaluation of D-dimer levels measured by different analytical methods in COVID-19 patients1
Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins1
Hematological treatment and prophylaxis in patients with and without inhibitors1
A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications1
Genetic analysis of compound heterozygous pathogenic variants of the F11 gene in two Chinese patients with hereditary factor XI deficiency1
Platelet aggregation response in children with infantile haemangioma under propranolol treatment1
The role of factor XIII in patient blood management1
Rotational thromboelastometry for diagnosis of fibrinolysis induced by urokinase in an in-vitro model1
Recessively inherited protein C deficiency in two sisters: intracerebral hemorrhage and coagulopathy complications1
Individualizing primary prophylaxis in patients with hemophilia A and B, adherence and new products1
The role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as venous thromboembolism predictors in breast cancer patients pre- and post-therapy1
The evaluation of reactive oxygen species generation and free mitochondrial DNA in platelet concentrates during 5 days of storage1
Whole blood thrombin generation hypercoagulable profile in a patient with hemolytic crisis due to paroxysmal nocturnal hemoglobinuria: a case report1
Comparison of bleeding and ischemic events with apixaban vs. rivaroxaban in triple antithrombotic therapy regimens1
Assessment of clinical characteristics and treatment outcomes of pediatric patients with intracardiac thrombosis: a single-center experience1
Endothelium-biomarkers for postthrombotic syndrome: a case–control study1
New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants1
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT1
Self-limited thrombotic thrombocytopenic purpura1
The impact of neutrophil extracellular traps in coronavirus disease - 2019 pathophysiology1
The role of endothelial cell protein C receptor gene polymorphism in venous thromboembolic disease: a case report and literature review1
The coexistence of antiβ2 glycoprotein 1 antibody antibody has no effect on hemophilia A patient1
Association of hemostasis and inflammation biomarkers with outcomes in acute coronary syndromes1
Evaluation of paediatric immune thrombocytopenia patients with clinical and laboratory findings: emphasizing the role of monocytosis1
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma1
New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier1
Acquired factor V and factor X Deficiency coexisting with acquired dysfibrinogenaemia in a patient with light chain myeloma1
True vs. false immune-mediated thrombotic thrombocytopenic purpura exacerbations: a clinical case in the caplacizumab era1
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose1
The most common disease-causing mutation of factor XIII deficiency is corrected by CRISPR/CAS9 gene editing system1
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen1
Incidence of factor XII deficiency in critically ill patients with a prolonged activated partial thromboplastin time: a prospective observational study1
Comment on: coagulopathy following Crotaline snakebites in northeast Florida1
Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapy1
Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study1
Prenatal diagnosis for hemophilia A (intron 22 inversion) reveals a rare association with Klinefelter syndrome with diagnostic difficulties in molecular interpretation1
0.13663697242737